Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.48

€0.48

6.910%
0.03
6.910%
€4.50

€4.50

 
22.10.21 / Tradegate WKN: A2QJN3 / Name: Blackhawk Growth Corp. / Stock / Micro Cap /
Latest predictions
€4.00
15.10.21
10.19%
buy
€5.00
13.10.21
10.70%
buy
Best running prediction
€5.00
13.10.21
10.70%
buy
Your prediction

Blackhawk Growth Corp.o Stock

Blackhawk Growth Corp.o dominated the market today, gaining €0.030 (6.910%).
With 0 Sell predictions and 2 Buy predictions the community sentiment towards the Blackhawk Growth Corp.o stock is not clear.
Based on the current price of €0.48 the target price of €4.00 shows a potential of 740.336% for Blackhawk Growth Corp.o which would more than double the current price.

Pros and Cons of Blackhawk Growth Corp.o in the next few years

Pros
?
Conscious of the environment
?
Worthwhile Investment for the next years
?
Brand
Cons
?
Growth compared to competition
?
Market Position
?
Shareholder structure
Tell us your opinion to access the 'Wisdom of the Crowds'

Other discussions about Blackhawk Growth Corp.o Stock

New thread Forum

News

Blackhawk Growth Appoints New Advisor to Support Expansion into Psychedelics and Mental Health Treatments

 

Vancouver, British Columbia – October 14, 2021 – Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that Dr. Lahiru Russell from Digital

Blackhawk Growth’s SAC Pharma Continues to Expand Product Line and Services

Vancouver, British Columbia – October 12, 2021 – Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ;) (the “Company”), is excited to provide an update on the expansion of products and operations

Blackhawk Growth's MindBio Therapeutics Brings Digital Mental Health Technology To Psychedelics Clinical Trials

 

Vancouver, British Columbia – October 7, 2021 – Blackhawk Growth Corp. (CSE:BLR; Frankfurt:0JJ) (the “Company” or “Blackhawk”) is pleased to announce that MindBio Therapeutics is developing